Alerts will be sent to your verified email
Verify EmailAAREYDRUGS
Aarey Drugs & Pharma
|
Syschem (India)
|
Bafna Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
5.07 % | -19.23 % | -52.11 % |
5yr average Equity Multiplier
|
2.28 | 6.28 | 3.77 |
5yr Average Asset Turnover Ratio
|
1.56 | 1.15 | 0.42 |
5yr Avg Net Profit Margin
|
1.44 % | -1.61 % | -36.55 % |
Price to Book
|
1.47 | 2.2 | 3.91 |
P/E
|
50.46 | 438.92 | 48.28 |
5yr Avg Cash Conversion Cycle
|
77.34 Days | -2.55 Days | 0.18 Days |
Inventory Days
|
20.31 Days | 94.02 Days | 87.65 Days |
Days Receivable
|
172.65 Days | 86.28 Days | 132.64 Days |
Days Payable
|
98.9 Days | 176.28 Days | 210.48 Days |
5yr Average Interest Coverage Ratio
|
4.14 | -19.05 | -5.68 |
5yr Avg ROCE
|
8.93 % | -3.72 % | -11.61 % |
5yr Avg Operating Profit Margin
|
1.54 % | 0.88 % | -21.98 % |
5 yr average Debt to Equity
|
0.21 | 0.82 | 1.41 |
5yr CAGR Net Profit
|
-4.17 % | n/a | 12.0 % |
5yr Average Return on Assets
|
2.26 % | -1.4 % | -16.11 % |
Shareholdings
|
|||
Promoter Holding
|
44.8 % | 57.02 % | 75.0 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-3.26 % | 40.68 % | -15.42 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Aarey Drugs & Pharma
|
Syschem (India)
|
Bafna Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|